Abstract
BackgroundIt is well known that aromatase inhibitors (AIs) increase the rate of bone mineral density (BMD) loss in the human skeleton. Patient characteristics that have been found to predict an...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
